Nippon India Pharma Fund

Nippon India Mutual Fund · Sectoral / Thematic · Regular Bonus · AMFI 102432 · ISIN INF204K01950
NAV₹591.242920 Nov 2026
3Y return—a year
5Y return—a year
Expense ratio1.83%₹9,087 Cr
Growth Score—

Returns

1M3M6MYTD1Y3Y5Y7Y10YSince launch
Fund——————————
NIFTY Pharma TRI+10.82%+7.43%+14.54%+25.40%+25.57%+22.02%+16.60%———
Category middle+6.83%+0.56%+8.02%+3.99%+3.08%+13.34%+11.84%+16.65%+14.59%—

Risk (36 months)

Volatility—
Sharpe—
Sortino—
Beta—
Alpha—
Deepest fall—
1-year periods with a loss—
5Y SIP XIRR—

Top holdings (31 Oct 2026)

Sun Pharmaceutical Industries Limited11.55%
Divi's Laboratories Limited6.73%
Cipla Limited6.21%
Lupin Limited6.16%
Dr. Reddy's Laboratories Limited6.13%
Apollo Hospitals Enterprise Limited5.10%
Mankind Pharma Limited4.40%
Sai Life Sciences Limited4.04%
Ajanta Pharma Limited3.53%
Max Healthcare Institute Limited3.31%
IPCA Laboratories Limited2.90%
GlaxoSmithKline Pharmaceuticals Limited2.83%

Sectors

Pharmaceuticals & Biotechnology75.0%
Healthcare Services21.8%
Retailing2.3%
Healthcare Equipment & Supplies0.5%

Calculated by Growth Analyser from AMFI NAVs and the fund house's disclosed portfolio. Up to 1 year: total return; longer: CAGR. Research and education only; not investment advice. Mutual fund investments are subject to market risks; read all scheme-related documents carefully. Past performance does not indicate future returns.